MarketCap
Facebook
X
Telegram
Navidea Biopharmaceuticals EV | NAVB
EV Jährlich Navidea Biopharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19.5 M | 30.3 M | 55.1 M | 21.3 M | 547 M | 1.17 B | 1.79 B | 2.57 B | 4.83 B | 4.3 B | 6.52 B | 4.87 B | 310 K | -5.64 M | -3.57 M |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 6.52 B | -5.64 M | 1.78 B |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Repare Therapeutics
RPTX
|
-9.3 M | - | - | $ 112 M |  Canada |
 |
Sesen Bio
SESN
|
66.6 M | - | 7.29 % | $ 127 M |  USA |
 |
Windtree Therapeutics
WINT
|
81.3 M | - | - | $ 26.8 M | USA |
 |
Trean Insurance Group
TIG
|
1.47 B | - | - | $ 316 M | USA |
 |
SQZ Biotechnologies Company
SQZ
|
-3.96 M | - | 57.95 % | $ 12.8 M | USA |
 |
MEI Pharma
MEIP
|
-4.64 M | - | 10.43 % | $ 20.5 M | USA |
 |
Palatin Technologies
PTN
|
-5.65 M | - | - | $ 13 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
14.1 M | - | - | - |  Russia |
 |
Lyra Therapeutics
LYRA
|
30.9 M | - | - | $ 24.9 M | USA |
 |
Brickell Biotech
BBI
|
515 K | - | -5.38 % | $ 6.06 M | USA |
 |
Applied Therapeutics
APLT
|
-49.7 M | - | - | $ 8.42 M | USA |
 |
ESSA Pharma
EPIX
|
-26.7 M | - | - | $ 8.86 M | Canada |
 |
Generation Bio Co.
GBIO
|
68.7 M | - | - | $ 344 M | USA |
 |
Clearside Biomedical
CLSD
|
44 M | - | - | $ 25.3 M | USA |
 |
Merus N.V.
MRUS
|
2.82 B | - | - | $ 5.78 B |  Niderland |
 |
RAPT Therapeutics
RAPT
|
-72 M | - | - | $ 2.36 B | USA |
 |
Annexon
ANNX
|
673 M | $ 4.2 | -0.36 % | $ 651 M | USA |
 |
AbbVie
ABBV
|
394 B | $ 294.72 | 0.32 % | $ 521 B | USA |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
-795 K | $ 4.63 | 21.05 % | $ 20 M |  Israel |
 |
Avenue Therapeutics
ATXI
|
-1.76 M | - | -52.27 % | $ 4.45 M | USA |
 |
Achieve Life Sciences
ACHV
|
126 M | $ 6.78 | 0.89 % | $ 296 M | USA |
 |
Axon Enterprise
AXON
|
33.2 B | $ 316.97 | 4.77 % | $ 24.7 B | USA |
|
TFF Pharmaceuticals
TFFP
|
7.83 M | - | -60.05 % | $ 125 K | USA |
 |
Bristol-Myers Squibb Company
BMY
|
184 B | $ 62.89 | 0.18 % | $ 128 B | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
143 M | - | -15.15 % | $ 60.3 M |  Britain |
 |
Axcella Health
AXLA
|
22.6 M | - | -16.42 % | $ 249 M | USA |
 |
Cytokinetics, Incorporated
CYTK
|
1.97 B | $ 58.59 | 4.29 % | $ 7.04 M | USA |
 |
Dynavax Technologies Corporation
DVAX
|
2.02 B | - | - | $ 2.02 B | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
43.3 B | $ 159.75 | 5.35 % | $ 20.9 B | USA |
 |
Amgen
AMGN
|
189 B | $ 467.97 | 0.59 % | $ 252 B | USA |
 |
Orgenesis
ORGS
|
38.8 M | - | -33.86 % | $ 61.2 M | USA |
 |
Codiak BioSciences
CDAK
|
284 M | - | -55.98 % | $ 2.15 M | USA |
 |
Jazz Pharmaceuticals plc
JAZZ
|
9.15 B | $ 248.31 | 1.17 % | $ 15.1 B |  Irlanda |
 |
Johnson & Johnson
JNJ
|
98 B | $ 280.31 | -0.17 % | $ 675 B | USA |
 |
Kala Pharmaceuticals
KALA
|
-3.43 M | $ 0.17 | 0.64 % | $ 1.39 M | USA |
 |
BioLineRx Ltd.
BLRX
|
5.66 B | $ 1.49 | -1.97 % | $ 3.67 B | Israel |
 |
Sage Therapeutics
SAGE
|
436 M | - | - | $ 527 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-721 K | $ 1.59 | -2.76 % | $ 2.62 M | Israel |
 |
Lineage Cell Therapeutics
LCTX
|
450 M | $ 1.13 | 8.17 % | $ 260 M | USA |
 |
Paratek Pharmaceuticals
PRTK
|
390 M | - | - | $ 121 M | USA |
 |
TCR2 Therapeutics
TCRR
|
92.6 M | - | - | $ 58.1 M | USA |
 |
C4 Therapeutics
CCCC
|
262 M | $ 2.9 | -3.5 % | $ 240 M | USA |
 |
Eli Lilly and Company
LLY
|
933 B | $ 1 437.4 | 0.36 % | $ 1.29 T | USA |
 |
ASLAN Pharmaceuticals Limited
ASLN
|
16.7 M | - | -14.27 % | $ 1.7 M |  Singapore |
 |
Compugen Ltd.
CGEN
|
106 M | $ 2.09 | -0.24 % | $ 195 M | Israel |
 |
Adverum Biotechnologies
ADVM
|
125 M | - | - | $ 86.2 M | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
4.14 B | $ 84.95 | 0.13 % | $ 7.99 B | USA |